Conquering hypertension in Vietnam-solutions at grassroots level: study protocol of a cluster randomized controlled trial

Duc A Ha, Oanh T Tran, Hoa L Nguyen, Germán Chiriboga, Robert J Goldberg, Van H Phan, Cuc T Nguyen, Giang H Nguyen, Hien V Pham, Thang T Nguyen, Thanh T Le, Jeroan J Allison, Duc A Ha, Oanh T Tran, Hoa L Nguyen, Germán Chiriboga, Robert J Goldberg, Van H Phan, Cuc T Nguyen, Giang H Nguyen, Hien V Pham, Thang T Nguyen, Thanh T Le, Jeroan J Allison

Abstract

Background: Vietnam has been experiencing an epidemiologic transition to that of a lower-middle income country with an increasing prevalence of non-communicable diseases. The key risk factors for cardiovascular disease (CVD) are either on the rise or at alarming levels in Vietnam, particularly hypertension (HTN). Inasmuch, the burden of CVD will continue to increase in the Vietnamese population unless effective prevention and control measures are put in place. The objectives of the proposed project are to evaluate the implementation and effectiveness of two multi-faceted community and clinic-based strategies on the control of elevated blood pressure (BP) among adults in Vietnam via a cluster randomized trial design.

Methods: Sixteen communities will be randomized to either an intervention (8 communities) or a comparison group (8 communities). Eligible and consenting adult study participants with HTN (n = 680) will be assigned to intervention/comparison status based on the community in which they reside. Both comparison and intervention groups will receive a multi-level intervention modeled after the Vietnam National Hypertension Program including education and practice change modules for health care providers, accessible reading materials for patients, and a multi-media community awareness program. In addition, the intervention group only will receive three carefully selected enhancements integrated into routine clinical care: (1) expanded community health worker services, (2) home BP self-monitoring, and (3) a "storytelling intervention," which consists of interactive, literacy-appropriate, and culturally sensitive multi-media storytelling modules for motivating behavior change through the power of patients speaking in their own voices. The storytelling intervention will be delivered by DVDs with serial installments at baseline and at 3, 6, and 9 months after trial enrollment. Changes in BP will be assessed in both groups at several follow-up time points. Implementation outcomes will be assessed as well.

Discussion: Results from this full-scale trial will provide health policymakers with practical evidence on how to combat a key risk factor for CVD using a feasible, sustainable, and cost-effective intervention that could be used as a national program for controlling HTN in Vietnam.

Trial registration: ClinicalTrials.gov NCT03590691 . Registered on July 17, 2018. Protocol version: 6. Date: August 15, 2019.

Keywords: Hypertension; Self-monitoring blood pressure; Storytelling; Trial; Vietnam.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
The adapted Chronic Care Model
Fig. 2
Fig. 2
Study flow
Fig. 3
Fig. 3
The schedule of enrolment, interventions, and assessments

References

    1. Vietnam Ministry of Health. Health Statistics Yearbook 2018, Ministry of Health, Hanoi, Vietnam. 2018.
    1. Nguyen TT, Hoang MV. Non-communicable diseases, food and nutrition in Vietnam from 1975 to 2015: the burden and national response. Asia Pac J Clin Nutr. 2018;27(1):19–28.
    1. Jamison DT, Breman JG, Measham AR, et al. Disease control priorities in developing countries. Second edition. Washington DC: World Bank Publications; 2006. p. 20433.
    1. Hoang VM, Dao LH, Wall S, et al. Cardiovascular disease mortality and its association with socioeconomic status: findings from a population-based cohort study in rural Vietnam, 1999-2003. Prev Chronic Dis. 2006;3(3):A89.
    1. Ministry of Health. Joint annual health review 2014-strengthening prevention and control of non-communicable disease. Hanoi: Medical Publishing House; 2015.
    1. Son PT, Quang NN, Viet NL, et al. Prevalence, awareness, treatment and control of hypertension in Vietnam-results from a national survey. J Hum Hypertens. 2012;26(4):268–280. doi: 10.1038/jhh.2011.18.
    1. Tran QB, VM, Hoang HL Vu, et al., Risk factors for Non-Communicable Diseases among adults in Vietnam: Findings from the Vietnam STEPS Survey 2015. J Glob Health Sci. 2020;2(1).
    1. Ha DA, Goldberg RJ, Allison JJ, et al. Prevalence, awareness, treatment, and control of high blood pressure: a population-based survey in Thai Nguyen, Vietnam. PLoS One. 2013;8(6):e66792. doi: 10.1371/journal.pone.0066792.
    1. Dower C, Knox M, Lindler V, et al. Advancing community health worker practice and utilization: the focus on financing. San Franciso, CA: National Fund for Medical Education/The Center for Health Professions; 2006.
    1. Alexander JA, Hearld LR. Methods and metrics challenges of delivery-system research. Implement Sci. 2012;7:15.
    1. Brownstein JN, Chowdhury FM, Norris SL, et al. Effectiveness of community health workers in the care of people with hypertension. Am J Prev Med. 2007;32(5):435–447. doi: 10.1016/j.amepre.2007.01.011.
    1. Turner BJ, Hollenbeak CS, Liang Y, et al. A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. J Gen Intern Med. 2012;27(10):1258–1264. doi: 10.1007/s11606-012-2095-4.
    1. Hurtado M, Spinner JR, Yang M, et al. Knowledge and behavioral effects in cardiovascular health: community health worker health disparities initiative, 2007-2010. Prev Chronic Dis. 2014;11:E22. doi: 10.5888/pcd11.130250.
    1. Nguyen HL, Ha DA, Goldberg RJ, et al. Culturally adaptive storytelling intervention versus didactic intervention to improve hypertension control in Vietnam- 12 month follow up results: a cluster randomized controlled feasibility trial. PLoS One. 2018;13(12):e0209912. doi: 10.1371/journal.pone.0209912.
    1. Nguyen HL, Allison JJ, Ha DA, et al. Culturally adaptive storytelling intervention versus didactic intervention to improve hypertension control in Vietnam: a cluster-randomized controlled feasibility trial. Pilot Feasibility Stud. 2017;3:22. doi: 10.1186/s40814-017-0136-9.
    1. Allison JJ, Nguyen HL, Ha DA, et al. Culturally adaptive storytelling method to improve hypertension control in Vietnam - “We talk about our hypertension”: study protocol for a feasibility cluster-randomized controlled trial. Trials. 2016;17(1):26. doi: 10.1186/s13063-015-1147-6.
    1. Agyemang C, Bruijnzeels MA, Owusu-Dabo E. Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa. J Hum Hypertens. 2005;20(1):67–71. doi: 10.1038/sj.jhh.1001923.
    1. Muntner P, Gu D, Wu X, et al. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension. 2004;43(3):578. doi: 10.1161/01.HYP.0000116302.08484.14.
    1. Cooper LA, Roter DL, Bone LR, et al. A randomized controlled trial of interventions to enhance patient-physician partnership, patient adherence and high blood pressure control among ethnic minorities and poor persons: study protocol NCT 00123045. Implement Sci. 2009;4(1):7. doi: 10.1186/1748-5908-4-7.
    1. Stergiou GS, Ntineri A, Kollias A. Changing relationship among office, ambulatory, and home blood pressure with increasing age: a neglected issue. Hypertension. 2014;64(5):931–932. doi: 10.1161/HYPERTENSIONAHA.114.04076.
    1. Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310(1):46–56. doi: 10.1001/jama.2013.6549.
    1. McManus RJ, Mant J, Haque MS, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799–808. doi: 10.1001/jama.2014.10057.
    1. Uhlig K, Patel K, Ip S, et al. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med. 2013;159(3):185–194. doi: 10.7326/0003-4819-159-3-201308060-00008.
    1. Ralston JD, Cook AJ, Anderson ML, et al. Home blood pressure monitoring, secure electronic messaging and medication intensification for improving hypertension control: a mediation analysis. Appl Clin Inform. 2014;5(1):232–248. doi: 10.4338/ACI-2013-10-RA-0079.
    1. van Onzenoort HA, Verberk WJ, Kroon AA, et al. Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension. J Hypertens. 2010;28(3):622–627. doi: 10.1097/HJH.0b013e328334f36b.
    1. Weiner BJ. A theory of organizational readiness for change. Implement Sci. 2009;4:67. doi: 10.1186/1748-5908-4-67.
    1. Adair R, Christianson J, Wholey DR, et al. Care guides: employing nonclinical laypersons to help primary care teams manage chronic disease. J Ambul Care Manage. 2012;35(1):27–37. doi: 10.1097/JAC.0b013e31823b0fbe.
    1. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2–4.
    1. Coleman K, Austin BT, Brach C, et al. Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood) 2009;28(1):75–85. doi: 10.1377/hlthaff.28.1.75.
    1. Cheng EM, Cunningham WE, Towfighi A, et al. Randomized, controlled trial of an intervention to enable stroke survivors throughout the Los Angeles County safety net to “stay with the guidelines”. Circ Cardiovasc Qual Outcomes. 2011;4(2):229–234. doi: 10.1161/CIRCOUTCOMES.110.951012.
    1. Dolor RJ, Yancy WS, Jr, Owen WF, et al. Hypertension Improvement Project (HIP): study protocol and implementation challenges. Trials. 2009;10:13. doi: 10.1186/1745-6215-10-13.
    1. Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10:53. doi: 10.1186/s13012-015-0242-0.
    1. Feldstein AC, Glasgow RE. A practical, robust implementation and sustainability model (PRISM) for integrating research findings into practice. Jt Comm J Qual Patient Saf. 2008;34(4):228–243.
    1. Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. doi: 10.1186/1748-5908-4-50.
    1. Kitson AL, Rycroft-Malone J, Harvey G, et al. Evaluating the successful implementation of evidence into practice using the PARiHS framework: theoretical and practical challenges. Implement Sci. 2008;3:1. doi: 10.1186/1748-5908-3-1.
    1. Rycroft-Malone J. The PARIHS framework--a framework for guiding the implementation of evidence-based practice. J Nurs Care Qual. 2004;19(4):297–304. doi: 10.1097/00001786-200410000-00002.
    1. Stetler CB, Damschroder LJ, Helfrich CD, et al. A guide for applying a revised version of the PARIHS framework for implementation. Implement Sci. 2011;6:99. doi: 10.1186/1748-5908-6-99.
    1. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248. doi: 10.1016/j.jacc.2017.11.006.
    1. Vietnam Ministry of Health. National Strategy on Prevention and Control of Cancer, Cardiovascular Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Asthma, and Other Non-Commnicable Diseases: Period 2015-2025. Hanoi: Ministry of Health; 2016.
    1. Miller WR, Rollnick S. Motivational interviewing: preparing people for change (2nd ed.) New York: The Guilford Press; 2002.
    1. Greaves CJ, Middlebrooke A, O'Loughlin L, et al. Motivational interviewing for modifying diabetes risk: a randomised controlled trial. Br J Gen Pract. 2008;58(553):535–540. doi: 10.3399/bjgp08X319648.
    1. Naar-King S, Outlaw A, Green-Jones M, et al. Motivational interviewing by peer outreach workers: a pilot randomized clinical trial to retain adolescents and young adults in HIV care. AIDS Care. 2009;21(7):868–873. doi: 10.1080/09540120802612824.
    1. Donner A, Klar N. Statistical considerations in the design and analysis of community intervention trials. J Clin Epidemiol. 1996;49(4):435–439. doi: 10.1016/0895-4356(95)00511-0.
    1. Fritz MS, Mackinnon DP. Required sample size to detect the mediated effect. Psychol Sci. 2007;18(3):233–239. doi: 10.1111/j.1467-9280.2007.01882.x.
    1. WHO, STEPS survey. . Accessed 17 Mar 2020.
    1. Rust J, Golombok S. Modern psychometrics, third edition: the science of psychological assessment. New York, NY: Routledge; 2009.
    1. Bonita R, De Counter M, Dwyer T, et al. Surveillance of risk factors for noncommunicable disease: the WHO STEPwise approach. Geneva: World Health Organization; 2001.
    1. Minh HV, Byass P, Chuc NT, et al. Gender differences in prevalence and socioeconomic determinants of hypertension: findings from the WHO STEPs survey in a rural community of Vietnam. J Hum Hypertens. 2006;20(2):109–115. doi: 10.1038/sj.jhh.1001942.
    1. Voils CI, Maciejewski ML, Hoyle RH, et al. Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care. 2012;50(12):1013–1019. doi: 10.1097/MLR.0b013e318269e121.
    1. Fernandez S, Chaplin W, Schoenthaler AM, et al. Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med. 2008;31(6):453–462. doi: 10.1007/s10865-008-9170-7.
    1. Ogedegbe G, Mancuso CA, Allegrante JP, et al. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol. 2003;56(6):520–529. doi: 10.1016/S0895-4356(03)00053-2.
    1. Ware J, Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–233. doi: 10.1097/00005650-199603000-00003.
    1. Pan Y, de la Puente M. Census Bureau guideline for the translation of data collection instruments and supporting materials: documentation on how the guideline was developed. 2005.
    1. Behling O, Law KS. Translating questionnaires and other research instruments: problems and solutions. London: Sage publications, Inc; 2000.
    1. Census Bureau Standard: Pretesting Questionnaires and Related Materials for Surveys and Censuses. 2003. .
    1. Green MC. Transportation into narrative worlds: the role of prior knowledge and perceived realism. Discourse Process. 2004;38(2):247–266. doi: 10.1207/s15326950dp3802_5.
    1. Green MC, Brock TC. The role of transportation in the persuasiveness of public narratives. J Pers Soc Psychol. 2000;79(5):701–721. doi: 10.1037/0022-3514.79.5.701.
    1. Strauss A, Corbin J. Basics of qualitative research: grounded theory, procedures, and techniques. Newbury Park, CA: Sage Publications; 1990.
    1. Denzin NK, Lincoln YS. The discipline and practice of qualitative research, in Handbook of Qualitative Research: Sage publications, Thousand Oaks, CA; 2000.
    1. Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol. 2001;27(1):363–385. doi: 10.1146/annurev.soc.27.1.363.
    1. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663–694. doi: 10.7326/0003-4819-134-8-200104170-00012.
    1. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. doi: 10.1136/bmj.c869.
    1. Austin PC, Manca A, Zwarenstein M, et al. A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals. J Clin Epidemiol. 2010;63(2):142–153. doi: 10.1016/j.jclinepi.2009.06.002.
    1. Senn S. Testing for baseline balance in clinical trials. Stat Med. 1994;13(17):1715–1726. doi: 10.1002/sim.4780131703.
    1. Albert PS. Longitudinal data analysis (repeated measures) in clinical trials. Stat Med. 1999;18(13):1707–1732. doi: 10.1002/(SICI)1097-0258(19990715)18:13<1707::AID-SIM138>;2-H.
    1. Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. Oxford: Clarendon Press; 1995.
    1. Edwards LJ. Modern statistical techniques for the analysis of longitudinal data in biomedical research. Pediatr Pulmonol. 2000;30(4):330–344. doi: 10.1002/1099-0496(200010)30:4<330::AID-PPUL10>;2-D.
    1. Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata. College Station, TX: State Press; 2005.
    1. Asia Pacific Cohort Studies, C. Barzi F, Patel A, et al. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health. 2007;61(2):115–121. doi: 10.1136/jech.2005.044842.
    1. Groenwold RH, Donders AR, Roes KC, et al. Dealing with missing outcome data in randomized trials and observational studies. Am J Epidemiol. 2012;175(3):210–217. doi: 10.1093/aje/kwr302.
    1. Little R, Rubin D. Statistical analysis with missing data, second edition. New York: John Wiley and Sons; 2002.
    1. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8(1):3–15. doi: 10.1177/096228029900800102.
    1. Ha DA, Chisholm D. Cost-effectiveness analysis of interventions to prevent cardiovascular disease in Vietnam. Health Policy Plan. 2011;26(3):210–222. doi: 10.1093/heapol/czq045.
    1. Hutton G, Baltussen R. Cost valuation in resource-poor settings. Health Policy Plan. 2005;20(4):252–259. doi: 10.1093/heapol/czi025.
    1. Hutubessy R, Chisholm D, Edejer TT. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff Resour Alloc. 2003;1(1):8. doi: 10.1186/1478-7547-1-8.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe